Results 131 to 140 of about 7,819 (191)

Editorial: Drug repurposing for cancer treatment: current and future directions. [PDF]

Front Oncol
Lampros M, Vlachos N, Lianos GD, Bali C, Alexiou GA.   +4 more
europepmc   +1 more source

Cryptotanshinone inhibits <i>Staphylococcus aureus</i> NdhC via uncompetitive inhibition: Collateral sensitivity in respiratory-deficient SCVs. [PDF]

Virulence
Xue ZJ, Huang MY, Wang JF, Zhong SY, Yang ZC, Xu J, Jin B, Chen NP, Qian CD.   +8 more
europepmc   +1 more source

Acute hypothermia induced by valproic acid. [PDF]

Proc (Bayl Univ Med Cent)
Dasara H, Conn B, Shamim S.
europepmc   +1 more source

Synergistic anticancer and antibacterial effects of novel regimens of phytopolyphenols and repurposing drugs on cultured cells. [PDF]

Oncol Res
Yeh YL, Wang YJ, Lin-Shiau SY.
europepmc   +1 more source

Synthesis and SAR evaluation of novel thioridazine derivatives active against drug-resistant tuberculosis [PDF]

European Journal of Medicinal Chemistry, 2017
The neuroleptic drug thioridazine has been recently repositioned as possible antitubercular drug. Thioridazine showed antitubercular activity against drug resistant mycobacteria but it is endowed with adverse side effects. A small library of thioridazine
Camila M Ribeiro, Fernando R Pavan, Sanjib Bhakta   +2 more
exaly   +8 more sources

Thioridazine: a selective inhibitor of peroxisomal β-oxidation in vivo [PDF]

FEBS Letters, 1985
In vivo administration of the phenothiazine drug, thioridazine, inhibits hepatic peroxisomal β-oxidation in mice. In starving animals, 3-hydroxybutyrate concentration is not decreased by thioridazine treatment.
Christiane van den Branden, C van den Branden, Frank Roels   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Concentrations of thioridazine and thioridazine metabolites in erythrocytes

Psychopharmacology, 1986
The concentrations of thioridazine and its main metabolites in erythrocytes from 61 thioridazine-treated patients were determined by gas-liquid chromatography. The mean and range of the erythrocyte concentrations, expressed as percentage of the corresponding plasma concentrations, were: thioridazine, 5.1% (2.0-10.6); side-chain sulfoxide, 5.6% (1.6-10 ...
C, Svensson, G, Nyberg, R, Axelsson, E, Mårtensson   +3 more
openaire   +2 more sources

Artifacts in the analysis of thioridazine and other neuroleptics

Journal of Pharmaceutical and Biomedical Analysis, 1993
Although the sensitivity to light of thioridazine and its metabolites has been described, the problem does not seem to be widely acknowledged. Indeed, a survey of the literature shows that assays of these compounds under light-protected conditions have ...
Clara Benzi Schmid, Pierre Baumann
exaly   +2 more sources